<rss version="2.0" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>Hacker News: loopasam</title><link>https://news.ycombinator.com/user?id=loopasam</link><description>Hacker News RSS</description><docs>https://hnrss.org/</docs><generator>hnrss v2.1.1</generator><lastBuildDate>Wed, 18 Nov 2026 04:07:34 +0000</lastBuildDate><atom:link href="https://hnrss.org/user?id=loopasam" rel="self" type="application/rss+xml"></atom:link><item><title><![CDATA[New comment by loopasam in "OpenAI seems to be silently re-enabling model training on Codex chats"]]></title><description><![CDATA[
<p>or simply using chat sessions for analytics and product prioritization (what are the topics users care about? What's trendy? Etc...)</p>
]]></description><pubDate>Tue, 03 Nov 2026 20:10:43 +0000</pubDate><link>https://news.ycombinator.com/item?id=50357496</link><dc:creator>loopasam</dc:creator><comments>https://news.ycombinator.com/item?id=50357496</comments><guid isPermaLink="false">https://news.ycombinator.com/item?id=50357496</guid></item><item><title><![CDATA[New comment by loopasam in "OpenAI seems to be silently re-enabling model training on Codex chats"]]></title><description><![CDATA[
<p>by using conversation traces and observed tool calls to capture the human reasoning and logic, and generating synthetic data from that for instance</p>
]]></description><pubDate>Tue, 03 Nov 2026 20:06:42 +0000</pubDate><link>https://news.ycombinator.com/item?id=50357439</link><dc:creator>loopasam</dc:creator><comments>https://news.ycombinator.com/item?id=50357439</comments><guid isPermaLink="false">https://news.ycombinator.com/item?id=50357439</guid></item><item><title><![CDATA[New comment by loopasam in "I’m joining OpenAI"]]></title><description><![CDATA[
<p>For me it is the simplicity of it (transparent minimal system prompts and harnest), you can extend it the way you like, I don't have to install a (buggy) Electron app (CC or Codex app), it integrates where I work, because it's simple (like in a standard terminal on VS code). I'm not locked in with any vendor and can switch models whenever I want, and most importantly, I can effectively use it within apps that are themselves using it as coding agent (the meta part - like a chat UI for very specific business cases). Being in TypeScript, it integrates very well with the browser and one can leverage the browser sandbox around it.</p>
]]></description><pubDate>Mon, 16 Feb 2026 19:44:04 +0000</pubDate><link>https://news.ycombinator.com/item?id=47039336</link><dc:creator>loopasam</dc:creator><comments>https://news.ycombinator.com/item?id=47039336</comments><guid isPermaLink="false">https://news.ycombinator.com/item?id=47039336</guid></item><item><title><![CDATA[New comment by loopasam in "I’m joining OpenAI"]]></title><description><![CDATA[
<p>pi is the most amazing piece of software I have interacted with, thanks for building it</p>
]]></description><pubDate>Mon, 16 Feb 2026 10:37:32 +0000</pubDate><link>https://news.ycombinator.com/item?id=47033430</link><dc:creator>loopasam</dc:creator><comments>https://news.ycombinator.com/item?id=47033430</comments><guid isPermaLink="false">https://news.ycombinator.com/item?id=47033430</guid></item><item><title><![CDATA[New comment by loopasam in "Linux Running in a PDF"]]></title><description><![CDATA[
<p>Believe it or not, that's my use-case for MS Edge, it has surprisingly decent features (for editing too)</p>
]]></description><pubDate>Thu, 06 Feb 2025 13:10:27 +0000</pubDate><link>https://news.ycombinator.com/item?id=42961966</link><dc:creator>loopasam</dc:creator><comments>https://news.ycombinator.com/item?id=42961966</comments><guid isPermaLink="false">https://news.ycombinator.com/item?id=42961966</guid></item><item><title><![CDATA[Moderna Digital Investor Event [pdf]]]></title><description><![CDATA[
<p>Article URL: <a href="https://s29.q4cdn.com/435878511/files/doc_events/2023/Nov/08/moderna-2023-digital-investor-event-presentation-final_online_v2.pdf">https://s29.q4cdn.com/435878511/files/doc_events/2023/Nov/08/moderna-2023-digital-investor-event-presentation-final_online_v2.pdf</a></p>
<p>Comments URL: <a href="https://news.ycombinator.com/item?id=38253441">https://news.ycombinator.com/item?id=38253441</a></p>
<p>Points: 2</p>
<p># Comments: 0</p>
]]></description><pubDate>Mon, 13 Nov 2023 18:31:57 +0000</pubDate><link>https://s29.q4cdn.com/435878511/files/doc_events/2023/Nov/08/moderna-2023-digital-investor-event-presentation-final_online_v2.pdf</link><dc:creator>loopasam</dc:creator><comments>https://news.ycombinator.com/item?id=38253441</comments><guid isPermaLink="false">https://news.ycombinator.com/item?id=38253441</guid></item><item><title><![CDATA[Too much mindfulness can spike anxiety]]></title><description><![CDATA[
<p>Article URL: <a href="https://www.bbc.com/worklife/article/20210202-how-mindfulness-can-blunt-your-feelings-and-spike-anxiety">https://www.bbc.com/worklife/article/20210202-how-mindfulness-can-blunt-your-feelings-and-spike-anxiety</a></p>
<p>Comments URL: <a href="https://news.ycombinator.com/item?id=28668261">https://news.ycombinator.com/item?id=28668261</a></p>
<p>Points: 2</p>
<p># Comments: 0</p>
]]></description><pubDate>Mon, 27 Sep 2021 08:09:59 +0000</pubDate><link>https://www.bbc.com/worklife/article/20210202-how-mindfulness-can-blunt-your-feelings-and-spike-anxiety</link><dc:creator>loopasam</dc:creator><comments>https://news.ycombinator.com/item?id=28668261</comments><guid isPermaLink="false">https://news.ycombinator.com/item?id=28668261</guid></item><item><title><![CDATA[New comment by loopasam in "The Joys of Being a Stoic"]]></title><description><![CDATA[
<p>My favorite reference book on the topic is: <a href="https://www.amazon.com/Practicing-Stoic-Philosophical-Users-Manual/dp/1567926118" rel="nofollow">https://www.amazon.com/Practicing-Stoic-Philosophical-Users-...</a></p>
]]></description><pubDate>Fri, 06 Nov 2020 15:14:36 +0000</pubDate><link>https://news.ycombinator.com/item?id=25008147</link><dc:creator>loopasam</dc:creator><comments>https://news.ycombinator.com/item?id=25008147</comments><guid isPermaLink="false">https://news.ycombinator.com/item?id=25008147</guid></item><item><title><![CDATA[New comment by loopasam in "Scientists use ML to find an antibiotic able to kill superbugs in mice"]]></title><description><![CDATA[
<p>A couple of good recent article to understand this complex problem (USA perspective): <a href="https://endpts.com/can-we-make-the-antibiotic-market-great-again/" rel="nofollow">https://endpts.com/can-we-make-the-antibiotic-market-great-a...</a> and <a href="https://endpts.com/biopharma-has-abandoned-antibiotic-development-heres-why-we-did-too/" rel="nofollow">https://endpts.com/biopharma-has-abandoned-antibiotic-develo...</a><p>Reasons are mainly: No incentive to develop antibiotics from a legal perspective (FDA), as insurance companies prefer to reimburse the cheap and generic, still working mostly "well enough" for now.<p><i>Insurers pay for in-patient antibiotics as part of a lump sum to hospitals known as a Diagnosis Related Group (DRG). Using a cheap antibiotic increases hospital profit margins, while using an expensive new drug could mean that a hospital might lose money by treating a given patient. As a result, hospitals are incentivized to use cheaper antibiotics whenever possible. This puts significant pricing pressure on new antibiotics, which are one of the only type of medicines paid for like this.</i></p>
]]></description><pubDate>Fri, 21 Feb 2020 10:55:23 +0000</pubDate><link>https://news.ycombinator.com/item?id=22382270</link><dc:creator>loopasam</dc:creator><comments>https://news.ycombinator.com/item?id=22382270</comments><guid isPermaLink="false">https://news.ycombinator.com/item?id=22382270</guid></item><item><title><![CDATA[New comment by loopasam in "Scientists use ML to find an antibiotic able to kill superbugs in mice"]]></title><description><![CDATA[
<p>A medicinal chemist take on it: <a href="https://blogs.sciencemag.org/pipeline/archives/2020/02/20/machine-learning-for-antibiotics" rel="nofollow">https://blogs.sciencemag.org/pipeline/archives/2020/02/20/ma...</a></p>
]]></description><pubDate>Fri, 21 Feb 2020 08:25:49 +0000</pubDate><link>https://news.ycombinator.com/item?id=22381706</link><dc:creator>loopasam</dc:creator><comments>https://news.ycombinator.com/item?id=22381706</comments><guid isPermaLink="false">https://news.ycombinator.com/item?id=22381706</guid></item><item><title><![CDATA[New comment by loopasam in "I Grew Up Gifted, but My Life Didn’t Turn Out the Way I Expected"]]></title><description><![CDATA[
<p>The popular book "Grit: The Power of Passion and Perseverance", explores this topic in more details, for those interested in the topic.</p>
]]></description><pubDate>Fri, 31 May 2019 11:33:24 +0000</pubDate><link>https://news.ycombinator.com/item?id=20059931</link><dc:creator>loopasam</dc:creator><comments>https://news.ycombinator.com/item?id=20059931</comments><guid isPermaLink="false">https://news.ycombinator.com/item?id=20059931</guid></item><item><title><![CDATA[Ask HN: Data scientists, how are you being evaluated within your company?]]></title><description><![CDATA[
<p>I've worked places of different sizes as data scientist (from start-up to mega-corp), and I've seen different ways to evaluate employee's performance (think yearly performance review). In my experience, it's ironically often difficult as a data scientist to demonstrate what you have or have not achieved during the year in a quantitative fashion. I would be curious to hear your input, what works and what doesn't in your opinion. Evaluation methodologies I have often seen are:<p>- Demonstration of impact on business: In this case it's up to the data scientist to justify as best as possible what business decision (or internal milestone) was made because of an analysis performed. In theory it makes sense (= your focus should be on impacting business), in practice I don't think I've ever seen a single analysis changing the course of anything; decisions are driven by many factors, your analysis being only one of them.<p>- Tool usage: I guess some programmers are evaluated the same way; basically, you develop a tool for co-workers to perform analyses with. The more the tool is used, the better it is for you (it's assumed that high usage = high business relevance). In this case the usage is sometimes easier to track and more impartial, but it's often difficult to develop a data science tool covering many use-cases, and one frequently ends-up with a niche product with low usage.</p>
<hr>
<p>Comments URL: <a href="https://news.ycombinator.com/item?id=19603164">https://news.ycombinator.com/item?id=19603164</a></p>
<p>Points: 17</p>
<p># Comments: 4</p>
]]></description><pubDate>Mon, 08 Apr 2019 08:13:13 +0000</pubDate><link>https://news.ycombinator.com/item?id=19603164</link><dc:creator>loopasam</dc:creator><comments>https://news.ycombinator.com/item?id=19603164</comments><guid isPermaLink="false">https://news.ycombinator.com/item?id=19603164</guid></item><item><title><![CDATA[New comment by loopasam in "Arts contributed $763B to US economy – more than agriculture or transport (2018)"]]></title><description><![CDATA[
<p>indeed, from the cited article (<a href="https://www.arts.gov/news/2018/arts-contribute-more-760-billion-us-economy" rel="nofollow">https://www.arts.gov/news/2018/arts-contribute-more-760-bill...</a>):<p>The arts saw a $20 billion trade surplus, leading with movies and TV programs and jewelry.</p>
]]></description><pubDate>Fri, 15 Mar 2019 14:26:04 +0000</pubDate><link>https://news.ycombinator.com/item?id=19399965</link><dc:creator>loopasam</dc:creator><comments>https://news.ycombinator.com/item?id=19399965</comments><guid isPermaLink="false">https://news.ycombinator.com/item?id=19399965</guid></item><item><title><![CDATA[New comment by loopasam in "AlphaFold at CASP13: What just happened?"]]></title><description><![CDATA[
<p>I worked a few years in pharma R&D (Roche, largest R&D budget in this industry).<p>In a pharma setting, the 3D structure of a protein is mostly used to perform drug design (<a href="https://en.wikipedia.org/wiki/Drug_design#Computer-aided_drug_design" rel="nofollow">https://en.wikipedia.org/wiki/Drug_design#Computer-aided_dru...</a>), i.e. trying to understand how a chemical will physically interact with a protein and thereby modify it's physiological function, in order to treat a disease.<p>The biggest problem comes from the fact that proteins are (1) non-static and very flexible and (2) don't exist in vacuum, they interact with a myriad of other entities in a living system. In other words, it's not because you know the structure of a protein and how to theoretically perturb it with a small molecule, that you have a drug. The large majority of structures predicted to be active against a protein target are not, when tested in a biological assay. The process helps, but ultimately it's a very empirical endeavor (test a ton of different chemicals in actual experiments, try to abstract some logic and move on from that). As a result, simply knowing the structure of a protein will not get you far down the line into finding a new drug.<p>On the resource topic: Even in a very large pharma setting, you will find only a dozen of scientists or so dedicated to the topic (out of tens of thousands employees), supporting many projects and with very little time to perform their own research. As a result, any team fully dedicated to the problem (like AlphaFold) can easily over-compete pharma. Most of the cost in drug discovery comes from dealing with patients and clinical trial. It's only at this stage that you'll know how your drug really works, and how it fits in the existing market and society (think of neuroscience for instance).<p>I don't want to undermine the protein structure field and AlphaFold results (it's fascinating), but pharma business model de facto relies very little on knowing a protein structure or not. It's also mostly useful to design small molecules, a class a bit out of fashion (biologics are the top-sellers in 2018, and new modalities are coming-up, like RNAs and gene editing for instance).</p>
]]></description><pubDate>Mon, 10 Dec 2018 14:56:48 +0000</pubDate><link>https://news.ycombinator.com/item?id=18648305</link><dc:creator>loopasam</dc:creator><comments>https://news.ycombinator.com/item?id=18648305</comments><guid isPermaLink="false">https://news.ycombinator.com/item?id=18648305</guid></item><item><title><![CDATA[New comment by loopasam in "Chan Zuckerberg Initiative Makes Its First Acquisition, Meta"]]></title><description><![CDATA[
<p>Also check out <a href="http://pubmed-watcher.org/" rel="nofollow">http://pubmed-watcher.org/</a> for biomedical domain</p>
]]></description><pubDate>Tue, 24 Jan 2017 10:22:47 +0000</pubDate><link>https://news.ycombinator.com/item?id=13470183</link><dc:creator>loopasam</dc:creator><comments>https://news.ycombinator.com/item?id=13470183</comments><guid isPermaLink="false">https://news.ycombinator.com/item?id=13470183</guid></item><item><title><![CDATA[New comment by loopasam in "Ask HN: How do you get notified about newest research papers in your field?"]]></title><description><![CDATA[
<p>If you're in the biomedical domain, you can use: <a href="http://pubmed-watcher.org/" rel="nofollow">http://pubmed-watcher.org/</a> (shameless plug, I wrote it)</p>
]]></description><pubDate>Fri, 05 Aug 2016 17:46:38 +0000</pubDate><link>https://news.ycombinator.com/item?id=12234331</link><dc:creator>loopasam</dc:creator><comments>https://news.ycombinator.com/item?id=12234331</comments><guid isPermaLink="false">https://news.ycombinator.com/item?id=12234331</guid></item><item><title><![CDATA[Guess the correlation]]></title><description><![CDATA[
<p>Article URL: <a href="http://guessthecorrelation.com/">http://guessthecorrelation.com/</a></p>
<p>Comments URL: <a href="https://news.ycombinator.com/item?id=10757783">https://news.ycombinator.com/item?id=10757783</a></p>
<p>Points: 2</p>
<p># Comments: 0</p>
]]></description><pubDate>Fri, 18 Dec 2015 10:42:59 +0000</pubDate><link>http://guessthecorrelation.com/</link><dc:creator>loopasam</dc:creator><comments>https://news.ycombinator.com/item?id=10757783</comments><guid isPermaLink="false">https://news.ycombinator.com/item?id=10757783</guid></item><item><title><![CDATA[New comment by loopasam in "Google is developing cancer and heart attack detector"]]></title><description><![CDATA[
<p>Nano-bubbles and particles have been used since a long time to diagnose diseases and enhance the quality of ultrasound analysis (contrast agents). You can also link an antibody on their surface to target them against a particular protein or reveal a zone of interest (e.g. a tumor revealed by a specific biomarker). Nano-bubbles are even use to destroy adjacent tissue on purpose (sonoporation).<p>Usually such particles are constructed via a mix of lipids and have a very short life time in the blood stream. I wonder how they're going to keep them alive in the blood stream for what seems to be a very long time and their design regarding toxicity.</p>
]]></description><pubDate>Tue, 28 Oct 2014 21:25:30 +0000</pubDate><link>https://news.ycombinator.com/item?id=8523697</link><dc:creator>loopasam</dc:creator><comments>https://news.ycombinator.com/item?id=8523697</comments><guid isPermaLink="false">https://news.ycombinator.com/item?id=8523697</guid></item><item><title><![CDATA[How to be productive]]></title><description><![CDATA[
<p>Article URL: <a href="http://visual.ly/how-be-productive">http://visual.ly/how-be-productive</a></p>
<p>Comments URL: <a href="https://news.ycombinator.com/item?id=8254588">https://news.ycombinator.com/item?id=8254588</a></p>
<p>Points: 5</p>
<p># Comments: 0</p>
]]></description><pubDate>Mon, 01 Sep 2014 20:37:33 +0000</pubDate><link>http://visual.ly/how-be-productive</link><dc:creator>loopasam</dc:creator><comments>https://news.ycombinator.com/item?id=8254588</comments><guid isPermaLink="false">https://news.ycombinator.com/item?id=8254588</guid></item><item><title><![CDATA[Curated list of Scala frameworks, libraries and software]]></title><description><![CDATA[
<p>Article URL: <a href="https://github.com/lauris/awesome-scala">https://github.com/lauris/awesome-scala</a></p>
<p>Comments URL: <a href="https://news.ycombinator.com/item?id=8019951">https://news.ycombinator.com/item?id=8019951</a></p>
<p>Points: 53</p>
<p># Comments: 24</p>
]]></description><pubDate>Fri, 11 Jul 2014 13:16:54 +0000</pubDate><link>https://github.com/lauris/awesome-scala</link><dc:creator>loopasam</dc:creator><comments>https://news.ycombinator.com/item?id=8019951</comments><guid isPermaLink="false">https://news.ycombinator.com/item?id=8019951</guid></item></channel></rss>